BamSEC and AlphaSense Join Forces
Learn More

Catalent Inc.

Formerly NYSE: CTLT

Indentures Filter

EX-4.1
from 10-Q 6 pages Description of Capital Stock
12/34/56
EX-4.4
from S-3ASR 55 pages Catalent, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 20__ Debt Securities
12/34/56
EX-4.1
from 8-K 170 pages Indenture Dated as of September 29, 2021 Among Catalent Pharma Solutions, Inc. the Guarantors Listed Herein Deutsche Bank Trust Company Americas as Trustee 3.500% Senior Notes Due 2030
12/34/56
EX-4.1
from 8-K 171 pages Indenture Dated as of February 22, 2021 Among Catalent Pharma Solutions, Inc. the Guarantors Listed Herein Deutsche Bank Trust Company Americas as Trustee 3.125% Senior Notes Due 2029
12/34/56
EX-4.1
from 8-K 177 pages Indenture Dated as of March 2, 2020 Among Catalent Pharma Solutions, Inc. the Guarantors Listed Herein Deutsche Trustee Company Limited as Trustee Deutsche Bank AG, London Branch as Principal Paying Agent and Deutsche Bank Luxembourg S.A. as Transfer Agent and Registrar 2.375% Senior Notes Due 2028
12/34/56
EX-4.7
from 10-K 10 pages Description of Capital Stock
12/34/56
EX-4.1
from 8-K 170 pages Indenture Dated as of June 27, 2019 Among Catalent Pharma Solutions, Inc. the Guarantors Listed Herein and Deutsche Bank Trust Company Americas as Trustee 5.00% Senior Notes Due 2027
12/34/56
EX-4.1
from 8-K 167 pages Indenture Dated as of October 18, 2017 Among Catalent Pharma Solutions, Inc. the Guarantors Listed Herein and Deutsche Bank Trust Company Americas as Trustee 4.875% Senior Notes Due 2026
12/34/56
EX-4.1
from 8-K 170 pages Indenture Dated as of December 9, 2016 Among Catalent Pharma Solutions, Inc. the Guarantors Listed Herein Deutsche Trustee Company Limited as Trustee Deutsche Bank AG, London Branch as Principal Paying Agent and Deutsche Bank Luxembourg S.A. as Transfer Agent and Registrar 4.750% Senior Notes Due 2024
12/34/56
EX-4.6
from S-8 29 pages Catalent, Inc. 2014 Omnibus Incentive Plan
12/34/56